Cel Sci CVM
NYSE CVM
$1.25 -0.06 (-4.91%)
As of: Nov 12, 2026 · 11:03 AM EST

Cel Sci (CVM) Purchase of Investments (2021)

Updated

Analysis

Cel Sci (CVM) Purchase of Investments (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 258.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 919.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 300.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.40 Bn
10 Cel Sci 58.11 Mn 32.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 -17.29 Mn
API Access

Cel Sci Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=CVM&period=max&api_key=YOUR_API_KEY